Cargando…
Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling
Muscle satellite stem cells (MuSCs) are responsible for skeletal muscle growth and regeneration. Despite their differentiation potential, human MuSCs have limited in vitro expansion and in vivo migration capacity, limiting their use in cell therapies for diseases affecting multiple skeletal muscles....
Autores principales: | Choi, SungWoo, Ferrari, Giulia, Moyle, Louise A, Mackinlay, Kirsty, Naouar, Naira, Jalal, Salma, Benedetti, Sara, Wells, Christine, Muntoni, Francesco, Tedesco, Francesco Saverio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549733/ https://www.ncbi.nlm.nih.gov/pubmed/36161772 http://dx.doi.org/10.15252/emmm.202114526 |
Ejemplares similares
-
Cellular dynamics of myogenic cell migration: molecular mechanisms and implications for skeletal muscle cell therapies
por: Choi, SungWoo, et al.
Publicado: (2020) -
Challenging the “chromatin hypothesis” of cardiac laminopathies with LMNA mutant iPS cells
por: Mozzetta, Chiara, et al.
Publicado: (2019) -
Generation of two genomic-integration-free DMD iPSC lines with mutations affecting all dystrophin isoforms and potentially amenable to exon-skipping
por: Ferrari, Giulia, et al.
Publicado: (2020) -
Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells
por: Dastidar, Sumitava, et al.
Publicado: (2018) -
Myogenic Precursors from iPS Cells for Skeletal Muscle Cell Replacement Therapy
por: Roca, Isart, et al.
Publicado: (2015)